 "There will be more Covid vaccine doses than needed by 2021 end: Pfizer CEO")
ATHENS (Reuters) - Pfizer's chief executive Albert Bourla said on Wednesday he was confident that by the end of 2021 there would be more vaccine doses than required to fight the COVID-19 pandemic.
"I feel very comfortable that by the end of 2021 we'll have more doses that we will need," Bourla told a virtual conference hosted in Athens.
"We are doing everything we can to increase the manufacturing capacity ... but the challenge is that we need to increase it in the next few months."
(Reporting by Michele Kambas and Renee Maltezou)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app